Sleep and Diabetes-Perfect et al stages of sleep (N1 and N2) 7,10 and in REM, 11 and less time in SWS. 7, 11 In contrast, 2 small studies 12,13 with children with T1DM did not show a difference in sleep architecture compared to healthy participants. However, these studies did demonstrate that participants with T1DM had more frequent and longer awakenings, 12 and arousals were associated with increased glucose variability during the night. 13 SDB has primarily been examined in adults with T2DM and those at risk for diabetes. [14] [15] [16] As the severity of SDB increases, there is an association with poor glucose control [14] [15] [16] [17] and complications of diabetes, such as neuropathy.
INTRODUCTION
Research has supported the role of slow wave sleep (SWS) in glucose maintenance and insulin sensitivity. 1, 2 Most research examining the association of sleep and risk of diabetes and/or its complications has focused on adults, and in particular, adults with type 2 diabetes (T2DM). Markedly less research has focused on children with type 1 diabetes (T1DM), one of the most common pediatric chronic medical conditions (1 in 300 for youth ages 10 to 19). 3 With the recognition that sleep may impact glucose regulation, it is important to determine the role that sleep plays in the management of diabetes in youth with T1DM.
Diabetes, Sleep, and Sleep Disordered Breathing
Inadequate amounts of sleep, sleepiness, anomalies in sleep architecture, and sleep disordered breathing (SDB) are aspects of sleep that may be particularly problematic for individuals at risk for or already diagnosed with T1DM or T2DM. [4] [5] [6] [7] Although sleep loss mostly has been implicated as a risk factor for T2DM, 8 Donga and colleagues found that sleep restriction contributed to reduced peripheral insulin sensitivity in adults with T1DM. 9 Sleep architecture may be altered in adults with T1DM and T2DM. In 3 studies, diabetic patients spent more time in lighter Sleep and Diabetes-Perfect et al
Home-Based Polysomnography (PSG)
Unattended overnight PSGs were completed with the Compumedics PS-2 system (Abbotsford, Victoria, Australia). We used the same montage consisting of EEG, ECG, and respiratory measurements that has been described previously in TuCASA studies. 34 The sleep studies were scored by a trained technician in accordance with the American Academy of Sleep Medicine (AASM) pediatric scoring guidelines. 35 The technician used the AASM pediatric hypopnea rule, 35 which was a > 50% drop in nasal pressure with a 3% drop in SaO 2 and/or accompanied by an arousal. Consistent with Kelly and colleagues, 32 we computed a Total-AHI that included all apneas (central and obstructive events) and hypopneas, as well as an obstructive AHI (O-AHI) that included obstructive apneas plus hypopneas.
School Sleep Habits Survey (SSHS)
The SSHS was used to address participants' sleep patterns (weekday and weekend), sleep disturbances (nighttime awakenings, trouble falling asleep, perceived sleep quality), depressed mood, sleepiness, and circadian preferences including school night and weekend variations over 2 weeks prior to taking the survey. 36, 37 The SSHS also contains a question about race/ethnicity and a question about self-reported grades, with higher scores representing worse grades. We describe scales, provide examples, and detail scoring in the appendices. Appendix 1 also provides information about how we recoded individual items to match the scaling of questions administered to the matched controls.
Diabetes Quality of Life Youth Version (DQOL-Y)
The DQOL-Y is composed of 58 items divided into 3 subscales: Life Satisfaction, Disease-Related Worries, and Disease Impact. The first subscale uses a 5-point Likert scale with anchors 1 = never or very unsatisfied to 5 = all of the time or very satisfied (range 17-85). Participants rate each item on the other 2 subscales using a 5-point Likert scale from 1 = never to 5 = all of the time (ranges 11 to 55, and 23 to 115, respectively), with higher scores reflecting worse diabetes quality of life.
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Pediatric Symptom Checklist (PSC)
Parents rated the frequency (0 = never to 2 = often) of their child's emotional, behavioral, or learning problems across 35 items.
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Medical Record Review
A medical records review was conducted to obtain the following information, if available: date or age of diagnosis, HbA1c, Tanner staging, height, weight, blood pressure, and other laboratory results. We used the height and weight within no more than 4 months of participation and computed BMI zscores and percentiles using formulae provided by the Centers for Disease Control and Prevention, adjusted for sex and age. Median household income using census tract data served as a proxy for socioeconomic (SES) status.
School Records
We obtained official school grades, most recent state standardized test scores (converted to z-scores), and attendance records (monthly absences and tardies). We manually computed grade point average (GPA) with all classes weighted equally.
ond aim was to examine the impact of sleep patterns on daytime functioning in youth with T1DM. We expected to find that elevated self-reported sleepiness in youth with T1DM would be related to compromised psychosocial functioning (i.e., behavioral problems, grades, and depression). The third aim was to compare the sleep of youth with T1DM to that of a matched control sample of youth without diabetes. We hypothesized that youth with T1DM would have significantly less SWS than controls.
METHODS
Participants
Youth (ages 10 through 16 years) with T1DM were recruited in a pediatric endocrinology clinic. There were no exclusions, other than psychiatric, cognitive, genetic (e.g., Down syndrome), or neurological conditions that could impact SDB or participation. Matched control participants were identified from the second examination of the Tucson Children's Assessment of Sleep Apnea (TuCASA) study, 33 who were recruited from the same geographic region as the youth with diabetes. For each diabetic participant with polysomnography (PSG) results, there was a TuCASA participant matched for sex, age, and body mass index (BMI) percentile.
Procedures
The local Human Subjects Protection Program approved this study. Research team members recruited potential participants during scheduled diabetes clinics in an endocrinology office over a one-year period. During this enrollment visit, adolescents and parents completed the consent and assent process. Once enrolled, adolescents had a continuous glucose monitor (CGM) inserted by a research team member who was certified by Medtronics and had an actigraph placed on the non-dominant wrist. Participants were provided with a blood glucose meter and strips, were instructed to use the provided meter ≥ 4 times a day for ≥ 5 days, and asked to document their levels on a glucose/food/activity log. They also were provided with a sleep diary during the period that the actigraph was worn to assist with scoring. During the 5-day period, participants who opted to undergo PSG (n = 47) completed the sleep study in their home. Approximately a week after the start of wearing the CGM and actigraph and filling out the glucose log and sleep diary, parent and child participants completed the appropriate questionnaires and then received compensation.
Measures
Continuous Glucose Monitoring System (CGM)
The CGM sensor (ipro CGM, Medtronics, Minneapolis, MN) was placed subcutaneously and the recorder was attached to the sensor. The interstitial blood glucose readings were sent every 5 min for the duration of the study and stored in the recorder. Participants were not able to view the glucose readings until the unit was downloaded. We examined average glucose levels across the total recording period, percentage of time spent hypoglycemic (≤ 60 mg/ dL), and percentage of time spent hyperglycemic (≥ 180 mg/dL).
Actigraphy
An actigraph (MiniMitter 64K, Portland, Oregon) was worn for approximately 5 days to examine multiday sleep-wake activity patterns.
ly less time in REM than those who identified themselves as non-White or Hispanic, t(31) = −2.59, P = 0.014 , d = 0.93, 95% CI [−7.64, −9.16]. Age was the only demographic or diseaserelated variable (e.g., BMI z-score, diabetes age onset) that was significantly related to HbA1c (P = 0.002). Diabetes duration was significantly correlated with CGM values (P = 0.025).
Sleep Parameters and Glucose Regulation
The associations between objective and self-reported sleep parameters and glucose regulation are shown in Table 2 , Figure 1 , and the correlation matrices in Appendix 2. In regard to SDB, regardless of the Total-AHI or O-AHI groupings, those with evidence of SDB had significantly more obstructive, central, and combined events than those without. There were 14 participants in the SDB group using the Total-AHI cutoff. Consistent with our hypothesis, participants with a Total-AHI ≥ 1. ) were not different between the groups. A reanalysis of the data using the O-AHI included 9 or 10 participants in the SDB group, for CGM and HbA1c data, respectively. There were no significant differences in glucose parameters between these 2 groups, but the pattern was the same with individuals with O-AHI ≥ 1.5 having higher glucose levels (204.56 mg/dL versus 174.96 mg/dL) and experiencing more hyperglycemia (50.67% versus 39.64%).
With regards to sleep architecture, less time spent in stage N3 was associated with higher HbA1c (P = 0.003; as shown in Appendix 2). We also found that percentage of time spent in stage N2 was positively associated with HbA1c (P < 0.001), average CGM glucose levels (P = 0.014), and the percentage of time hyperglycemic (P = 0.03). See Figure 1 for a scatterplot depicting the relation between stage N2 and HbA1c.
As can be seen on Table 3 , participants' average TST, as measured by actigraphy, was 6.96 h (SD = 1.01 h) and their mean sleep efficiency was 78.5% (SD = 9.99%). Overall sleep parameters did not relate to glucose control. TST each night also did not predict awakening glucose levels.
None of the self-reported sleep variables were related to glycemic control. The PSC was the only psychosocial variable related to HbA1c (P = 0.013). The PSC was also correlated with CGM glucose levels (P = 0.012) as well as DQOL-Y Disease Impact (P = 0.01).
Given that multiple variables correlated with glucose control, and in order to start the model-building process, we conducted 2 multiple regression analyses (see Table 4 ): one predicting CGM glucose values and the other predicting HbA1c. The variables significantly correlated with CGM average glucose values were the AHI cutoff, stage N2 (%), PSC score, DQOL-Y Disease Impact, and diabetes duration; together these variables significantly predicted CGM glucose levels, F 5,30 = 7.15, P < 0.001, MSE = 35.09, R 2 = 0.54, where MSE is the mean square error. In a manual backward elimination process so predictors
Variables for Matched Controls
Sleep studies for control participants were conducted using the same equipment and rescored by the same technician using the AASM scoring guidelines. 35 Methodology for recruitment and study design have been described previously. 34 Parental self-reported income served as a marker of SES. Control participants also completed a screening questionnaire that included the items that were similar to items on the SSHS; however, they had to be modified to have similar scaling. The specific items and recodes are available in Appendix 1.
Data Analyses
Pearson correlations were used to examine the relations between sleep architecture and self-reported sleep variables with measures of psychosocial functioning. Because of skewness, average monthly absences were log-transformed. Independent ttests (using equal variances not assumed due to unequal sample size) were used to compare the effect of SDB (Total-AHI ≥ 1.5) on glucose levels. Data were also reexamined using O-AHI to define groups of < or ≥ the 1.5 cutoff to assess the impact of only obstructive events. Cohen's d was the measure of effect size. The Kruskal-Wallis statistic was used to determine if obstructive or central apneas differed according to SDB groupings. A generalized linear mixed effects model, with participants as the random intercept, was employed to examine if TST each night predicted awakening glucose values the next day (glucose reading that intersected with awakening and one immediately following awakening). Paired t-tests were used to compare sleep architecture of the diabetes sample with matched controls' sleep architecture. Cohen's d for within subject analyses served as the measure of effect size. To determine if any differences in sleep architecture were attributable to SDB, we also ran 2 mixed design between-within ANOVAs with SDB (Total-AHI and O-AHI groupings) as the between factor and matched pairs as the within factor. The Wilcoxon signed rank test was employed for within-group comparisons of respiratory parameters, which were skewed. All analysis used an α level of 0.05 for significance testing unless otherwise noted.
RESULTS
Demographic Information
Out of the 50 participants, there were 40 valid PSGs, with 3 participants opting not to do a sleep study, one study being inadvertently erased from the computer, one study accidently being recorded over, one study not downloading from the card, and 4 participants having connection problems. Table 1 provides the sample characteristics; there were no significant differences in demographic or health variables between the full diabetic cohort and the ones who had valid PSG data. There were 47 participants with 1 to 6 days of CGM data; one CGM was not downloaded, one sensor was not returned by the participant, and one downloaded without data. Actigraphy data (n = 49) ranged from 2 to 7 days, with one not downloaded. Table 2 contains a summary of the PSG, actigraph, and selfreported questionnaire data of psychosocial variables. As it is well recognized, 40, 41 stage N2 significantly increased with age, r(40) = 0.49, P = 0.001, whereas stage N3 significantly decreased with age, r(40) = −0.58, P < 0.001. Individuals who identified themselves as White, Non-Hispanic spent significant-P < 0.001, MSE = 1.32, were: age, β = 0.28, P = 0.061; stage N2 (%), β = 0.28, P = 0.085; and PSC scores, β = 0.27, P = 0.070.
Self-Reported Sleepiness, Psychosocial Functioning, and Sleep Architecture
Supporting our hypothesis, self-reported daytime sleepiness significantly related to compromised psychosocial functioning (see Appendix 2) . Specifically, greater daytime sleepiness (SSHS Sleepy2) related to lower SSHS Grades (P < 0.001), greater DQOL-Y Disease Impact (P = 0.001), reduced DQOL-Y Life Satisfaction (P = 0.004), more DQOL-Y Diabetes-Related with P-values less than 0.10 were removed, the variables that remained in the model, F 4,32 = 9.73, P < 0.001, MSE = 34.45, R 2 = 0.55, were: AHI, β = 0.35, P = 0.006; stage N2 (%), β = 0.29, P = 0.036; PSC scores, β = 0.29, P = 0.040; and diabetes duration, β = 0.33, P = 0.011.
The variables significantly correlated with HbA1c values were age, stage N2 (%), stage N3 (%), and PSC score; together these variables significantly predicted HbA1c, R 2 = 0.45, F 4,35 = 7.09, P < 0.001. In a manual backward elimination process so predictors with P-values less than 0.10 were removed, the variables that remained in the model, R 2 = 0.43, F 3,36 = 9.11, N2 were more likely to have higher average daily glucose values, experience more hyperglycemia, and have higher HbA1c levels. Moreover, stage N2 was associated with parental reports of emotional and behavioral difficulties, reduced diabetes quality of life, lower grades, sleep-wake behavior problems, depressive mood, daytime poor sleep quality, sleepiness, and worse math performance. The associations between sleep architecture with poor glycemic control and diminished daytime functioning is particularly problematic given that we also found that youth with T1DM spent significantly more time (%) in stage N2 and less time in SWS than matched controls. Further, although groups had comparable Total-AHIs and O-AHIs, youth with diabetes had more central apneas.
This study adds to the burgeoning evidence that SDB may result in higher glucose levels. 14, 15, 17, 42 Using the Total-AHI, the data supported large effects of at least mild SDB negatively impacting daily CGM values and hyperglycemia. To put it into perspective, the mean glucose level of the SDB group was above the hyperglycemic cut-off (≥ 180 mg/dL), whereas the mean of the non-SDB group although still high, was below the hyperglycemic range. Using the same cutoff (Total-AHI ≥ 1.5), Kelly and colleagues 32 found that individuals with SDB had greater insulin resistance relative to individuals without SDB. Further, our data are consistent with findings reported by Villa and colleagues 17 and as well as the Sleep Heart Health Study. 43 In these studies, individuals with diabetes presented with more central breathing abnormalities relative to non-diabetics, suggesting that diabetics may have a defect in central respiratory control. When SDB groupings were based on O-AHI (i.e., without central events), our results did not achieve statistical significance. Nevertheless, qualitatively similar patterns were found. We believe that the mean differences between groups are still notable because the findings suggest that both central and obstructive events have the potential to negatively impact glycemic control. Ultimately, a larger sample will be needed to fully understand the role of SDB and its various subtypes on glucose dysregulation in youth with T1DM. A longitudinal perspective would also help
Sleep Architecture and SDB Differences Between Diabetic Cohort and Controls
The diabetes sample was comparable to matched controls in regard to demographics; they were within 0.05% of a BMI percentile and less than 10% of a month (~3 days) apart from each other (see Table 1 ). Table 5 There was no significant difference in Total-AHI, z = −0.57, P = 0.57, r = 0.06 or O-AHI, z = −0.75, P = 0.47, r = 0.09, between the matched pairs. Findings from exploratory analyses revealed that youth with diabetes experienced significantly more central apneas per hour, z = −2.19, P = 0.029, r = 0.32 than their matched pairs. Including the SDB groupings (Total-AHI and O-AHI) as a variable did not affect the differences in sleep architecture between diabetics and non-diabetics.
In regards to recoding of the self-report measures, crosstabulations and Spearman rank-order correlational analyses indicated significant associations between the original variables and the recoded responses for both groups. Relative to controls, participants from the diabetic cohort reported comparable rates of sleepiness, trouble falling asleep, early morning awakening, and falling asleep in school and watching television.
DISCUSSION
Our findings support that even mild SDB appears to contribute to higher glucose levels and hyperglycemia in youth with T1DM. 17 Although this study supports previous findings that reduced SWS is associated with poorer glucose regulation, 1,2 we found that youth who spent a greater proportion of time in stage This study is not without limitations. First, the study design and statistical analyses did not control for insulin dosage, a critical factor in glucose regulation in T1DM. Second, the low number of participants with AHI ≥ 5 precluded meaningful analyses of the impact of more severe SDB. For future studies, it may help to exclude those with intermediate AHI and compare differences between children without SDB and with more clear-cut SDB. Third, with respect to our matched controls, due to the small number of participants, we did not include Tanner staging or race/ethnicity as part of matching criteria. One previous study did find a small difference in staging according to this latter characteristic for younger participants 41 and we found differences in REM. Nonetheless, although we cannot definitively exclude the possibility that race/ethnicity confounded our results, there were comparable proportions of Whites and nonWhites in both samples. Fourth, we conducted a large number of analyses with a modest sample size without a correction to adjust for multiple hypothesis testing. Although the possibility of type I error exists and findings need to be replicated, the associations were internally consistent with each other, in the expected direction in most cases, and consistent with previous literature. Finally, we used actigraphy as an estimate of sleep and wakefulness during the CGM measurements rather than PSG. Although PSG would have provided actual measurements of sleep architecture, it is not feasible for continuous serial data collection over several days. Moreover, in the absence of overt insomnia or SDB, estimates of sleep and wakefulness with actigraphy correlate well with PSG data.
Overall, this study supports the need to inquire about sleepiness and sleep habits as part of the clinical care of youth with T1DM. Clinicians and school-based professionals need to be aware that reports of daytime sleepiness, disrupted sleep, or poor sleep habits, may affect patients' daytime functioning, including the possibility of interfering with their diabetes selfcare,quality of life, and school performance. Future research is also needed to determine the exact prevalence of SDB in youth with T1DM and its impact on metabolic function to determine if universal PSG screening is appropriate. Percent of time in stage N2 in particular was associated with several potentially adverse outcomes and this stage of sleep also needs to be examined further in this population.
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Although stage N3 was related to HbA1c, stage N2 also related to glycemic control and remained in the model. It is important to keep in mind that these data are correlational and do not mean that sleep problems cause glucose dysregulation, or vice versa. However, they are consistent with the physiological mechanisms that occur during sleep. For instance, there is normally more parasympathetic than sympathetic activity during SWS. If there is less SWS, then sympathetic activity is more likely to predominate. Sympathetic activity means more release of certain counterregulatory hormones (e.g., epinephrine), which may increase glucose. 1, 2 Using daily TST estimated by the actigraphy, youth slept less than the recommended nine hours of sleep. However, we did not find that sleep duration predicted awakening glucose values. Future research needs to further examine the impact of sleep restriction 9 or short sleep duration on awakening and day-to-day variability in glucose levels in T1DM, taking into account other factors implicated in glucose regulation, particularly insulin, diet, and physical activity.
These findings lend support for the role of sleepiness in depressive symptoms, 36 reduced diabetes quality of life, and perceptions of lower grades. Poor sleep habits also associated with these psychosocial variables as well as parental reports of emotional and behavioral difficulties and worse performance in reading. Less attention has been paid to sleep architecture and school-related outcomes. Youth with diabetes are already at-risk for school-related problems. 44 The finding related to the associations of perceived and actual grades as well as math performance with stage N2 should serve as an impetus for future research to better understand the role of sleep in altering school functioning in youth with diabetes.
Unlike large cohort studies, 25, 29, 30 the current study did not find that mild SDB was related to psychosocial outcomes. However, this finding is partially consistent with previous research, 45 as it is likely that these effects are more noticeable with more severe SDB. 26, 28, 30 We chose to use the Total-AHI with a cut-off of 1.5 as our referral for further evaluation and for statistical analyses based on previous literature on SDB in pediatric populations. 31, 32 Future research should examine the joint impact of sleep related respiratory problems and glucose dysregulation in youth with T1DM on SDB and diabetes symptoms as well as daytime functioning with larger samples and longitudinally. Research would be enhanced by including neurocognitive measures, which have been found to be affected by SDB 22, 23 and glycemic control. 46 Supporting our hypothesis and previous findings, 7, 11 youth with T1DM spent significantly more time in stage N2 and less time in stage N3 than non-diabetics. The difference was approximately 5% of the night, which means based on a 7-hour night, youth with diabetes would spend 21 minutes less in SWS. Thus, even though it is slightly less than a half hour, this pattern of sleep architecture is associated with worse glycemic control and problems in sleepiness, mood, behavior, quality of life, and school performance. ; Ns differ slightly based on missing items on questionnaire and for school-related data based on school records provided; *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001; State standardized Writing scores, Tardies, and Absences were not included as they had no significant relations with sleep parameters.
